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Abstract The mycotoxin ochratoxin A (OTA) is a
common contaminant of many foodstuffs and, conse-
quently, is present in a large proportion of tested pop-
ulations of humans and commercial animals. The
predominant effects of OTA are manifested in the kid-
ney where the severity varies from salt wasting to renal
carcinoma formation in a concentration-dependent
fashion. The MDCK-C7 renal cell culture model re-
sponds to various hormones known to regulate electro-
lyte and fluid balance and was used as a model to study
the chronic effects of an acute exposure to low dose
OTA. The natriferic hormones aldosterone and insulin-
like growth factor 1 (IGF1) both stimulate Na+ flux in a
reabsorptive direction via activation of the epithelial
Na+ channel (ENaC). In contrast, anti-diuretic hor-
mone (ADH) stimulates three separate and temporally
distinct ion transport responses, one of which is Na+
reabsorption. Treatment of MDCK-C7 cells with OTA
(100 nM) for 48 h selectively and irreversibly inhibits
hormone-stimulated Na+ reabsorption via ENaC. This
effect was retained for 48 cell passages after the removal
of the toxin and mimics the OTA-induced salt-wasting
that has been documented in clinical studies. These
studies indicate that the effect of the toxin is genomic
and therefore, likely to be long lasting in exposed ani-
mals and humans.
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Introduction
Ochratoxin A (OTA) is a fungal metabolite produced by
several Aspergillus and Penicillium species. Because of
the ubiquitous presence of these fungi, the toxin is
commonly found in grains, coffee, wine, animal feed and
animal products [3, 4, 5]. OTA is remarkably stable and
remains effective after processing treatments such as
cooking, brewing or roasting. In addition, binding of the
toxin to serum proteins such as albumin ensures a rel-
atively long half life in the blood [4]. In populations such
as Europe, Canada, the United States and northern
Africa, where animal and human serum levels have been
monitored, there is a high incidence of measurable to
toxic levels in the population [4, 11, 12, 16, 20].
The toxin appears to concentrate in certain organs,
notably the kidney. Concomitantly, the kidney is also
one of the major organs affected by OTA. In vivo studies
in rats have demonstrated a very sensitive effect of OTA
on post-proximal nephron function [5] with subsequent
studies indicating that acute exposure has a predominant
effect on reabsorptive transport functions in the distal
nephron [4]. The nature of the effect on electrolyte and
nutrient excretions, predominately a toxin-induced in-
crease in NaCl excretion and a decrease in K+ excretion,
confirm an action on the distal nephron/ collecting duct.
Chronic or high level exposure has more global renal
effects including reduction in renal blood flow and glo-
merular filtration, proximal and distal tubular function,
and the development of carcinogenic properties [4, 5]. In
areas of very high levels of human exposure, epidemio-
logical studies have linked OTA as the causative agent in
Balkan endemic nephropathy, renal adenomas and car-
cinomas [12, 16, 21]. The epidemiological studies have
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been supported by animal and tissue culture studies
demonstrating specific uptake by renal cells [18], effects
of OTA on growth and apoptosis in renal epithelial cells
[7, 9, 10], effect of hormonal signaling via epidermal
growth factors [1] or extracellular signal-regulated kin-
ases, ERK [18] and induction of oxidative stress and
proximal tubular toxicity [17].
Many of the in vitro studies use levels of the toxin
that exceed typical concentrations of in vivo exposure. It
is of interest, therefore, to explore the long-term effects
of physiologically relevant toxin concentrations. Previ-
ous studies have shown that acute exposure to nanom-
olar concentrations of OTA altered the ability of the
cells to regulate pH by inhibiting anion conductance.
Dome formation in MDCK (Madin Darby canine kid-
ney) cells was also inhibited indicating an effect on salt
and water movement [4, 5, 8]. When a principal cell
subclone of the MDCK line (MDCK-C7) was exposed
to 100 nM OTA for 48 h, the resultant cell line showed
irreversible changes in both function and genotype. The
predominant changes in function were a diminished
basal K+ secretory rate and a loss of responsiveness to
aldosterone. In addition, the OTA-treated cells main-
tained a higher transepithelial resistance than the naı¨ve
MDCK-C7 line. The genotypical changes appeared to
be numerical aberrations with no specific changes in
karyotype [8].
In the present studies we have extended the experi-
ments using the OTA-treated MDCK-C7 cells. After the
single exposure, the functional effects on the cell line
were monitored for an additional 48 passages over the
course of several years. We found a specific and irre-
versible defect in reabsorptive Na+ transport in re-
sponse to hormonal stimuli. The permanency of the
change suggests an alteration which is likely mediated at
the genomic level. Cellular viability as well as other ion
transport responses remained unchanged.
Materials and methods
MDCK-C7 cell culture:
The MDCK-C7 cell line is a subclone of the heteroge-
neous MDCK cell line. This subclone has the charac-
teristics of the principal cells of the distal nephron [6]
and responds to hormonal stimuli known to regulate ion
transport in the distal nephron [2,13]. The MDCK-C7
cells form a high resistance (>1,000 W/cm2) monolayer
when grown on permeable supports.
The MDCK-C7 cells were maintained in a 37C
incubator with 5% CO2 and 95% O2 gas mixture. Cells
were carried in 75-ml flasks and fed with MEM with
Earle’s salt, nonessential amino acids and L-glutamine
(MEM; Gibco/BRL, Grand Island, N.Y., USA) sup-
plemented with 10% fetal bovine serum (Sigma, St
Louis, Mo., USA), 26 mM NaHCO3, 25 U/ml penicillin
and 25 lg/ml streptomycin and adjusted to pH 7.0.
Cellular media was changed thrice weekly and the cells
were subcultured by trypsinization every 5–7 days. For
functional assays, the cells were seeded (5.5·104 cells/
cm2) onto Nucleopore polycarbonate membranes
forming the bottom of Transwell chambers (Costar,
Cambridge, Mass., USA). The Transwell chambers form
a two-compartment system in which media can be added
to both apical and basolateral surfaces. The cells were
used 7–11 days after plating onto the permeable sup-
ports.
To study the effect of OTA, the cells were treated for
48 h with 100 nM OTA and subsequently cultured in
OTA-free media [8]. The cells were grown on culture
flasks or permeable supports, trypsinized, frozen in li-
quid N2, re-extracted from the liquid N2 and plated onto
permeable supports for 48 passages after the initial
treatment with OTA.
Functional assays
Standard Ussing-style electrophysiological techniques
were used to examine net ion transport across the cel-
lular monolayers [2, 13, 23]. Nucleopore filters contain-
ing confluent monolayers were removed from the
Transwell chambers and clamped between the halves of
an Ussing chamber (World Precision Instruments, Sar-
asota, Fla., USA). The chamber contains ports for
insertion of voltage electrodes (close to the tissue) and
current electrodes (at opposite ends of the chamber). The
chamber also contains ports for attachment to water-
jacketed buffer reservoirs where the buffer is maintained
at 37C and circulated through the electrophysiology
chamber by means of a 5% CO2/O2 gas lift. Unless
otherwise stated, the bathing media was serum-free
MEM. For the ion substitution experiments, the control
cultures were equilibrated and measured in Kreb’s/
Henseleit media (116.4 mM NaCl, 25 mM NaHCO3,
0.6 mM NaH2PO4, 2.5 mM CaCl2, 4.1 mM KCl,
0.6 mM KH2PO4, 1.2 mM MgSO4, 11.1 mM glucose
and 1.2 mM HCl, pH 7.1). The Cl– free cultures were
incubated and measured in Kreb’s/Henseleit in which
Cl was replaced with NO3
. The electrodes were con-
nected to a voltage-clamp amplifier (Current Voltage
Clamp; World Precision Instruments) for measurement
of net ion flux as short-circuit current (SCC). Transepi-
thelial resistances were calculated every 200 s by apply-
ing a 2-mV pulse across the epithelium and measuring
the resultant deflection in SCC. Cultures were used only
if the resistance was ‡1,000 W/cm2. The calculated po-
tential difference across the epithelia changes in parallel
with the change in SCC.
Cultures were monitored in the Ussing chambers
under short-circuit conditions for at least 0.5 h or until a
stable baseline current was obtained. Hormones were
added to the serosal bathing media; amiloride (105 M)
was added to the apical bathing media. The data are
presented as mean±SEM with n indicating the number
of experiments. Student’s t-test was used for statistical
comparison with P £ 0.05 considered significant.
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Analysis of ENaC subunit protein expression
MDCK-C7 and OTA-treated MDCK-C7 cells were
grown to confluence on permeable supports (11–
19 days), washed three times with cold serum-free
media and scraped from the filter support in 500 ll of
lysis buffer (0.14 mM SDS, 10% glycerol, 1 mM DTT,
in 0.05 M TRIS pH 6.8, 5% protease inhibitor cock-
tail). To effect solubilization, cell lysates were sonicated
for 20 1-s pulses with a titanium-tip sonicator (20%
duty cycle, Granson Sonifier 450) and stored at
20C.
Cell lysates were separated using 7.5% polyacryl-
amide gels and subsequently transferred to PVDF
membranes. One of a duplicate pair of the PVDF
membranes was stained with Coomassie brilliant blue
protein stain to show equal sample loading. The other
duplicate PVDF, used for antibody probing, was wa-
shed once in 1·TRIS-buffered saline (TBS) pH 7.5 for
10 min then blocked with 5% nonfat milk in TBS,
pH 7.5 for 1 h. The PVDF was washed again in TBS
for 10 min then incubated in the primary antibody
solution (a, b, or c ENaC [22]) in 0.5% milk in TBS
overnight at 4C. The PVDF was washed again in TBS
for 10 min and then incubated with goat anti-rabbit
antibody conjugated with horseradish peroxidase di-
luted in 0.5% milk in TBS for 1.5 h. A series of six to
seven washes in TBS for 10 min occurred after the
secondary antibody incubation, the second of which
was in 0.05% Tween-TBS, pH 7.5. For viewing specific
bands, SuperSignal West Dura Extended Duration
Substrate (Pierce Chemical, Rockford, Ill., USA) was
used according to the manufacturer’s protocol and
exposed on Hyperfilm (Amersham, Piscataway, N.J.,
USA) to view the antibody binding.
Results
MDCK-C7 cells were treated with 100 nM OTA in
normal serum-free growth media for 48 h. The cells were
then further cultured in the absence of OTA for an
additional 48 passages. During the culturing procedure,
cells were also placed in liquid N2 for long-term storage,
thawed and plated. The treated cells were indistin-
guishable from the untreated MDCK-C7 cells in growth
and viability characteristics in response to all culturing
conditions.
We have previously shown that the MDCK-C7 cell
line demonstrates natriferic (Na+ retaining) responses
to aldosterone (106 M) and IGF1 (insulin-like growth
factor 1; 100 nM) [2]. After treatment with OTA, the
responses to these two hormones were completely
abolished and the cells had no amiloride-sensitive
current either before or after hormone stimulation.
This specific loss of transepithelial Na+ transport was
maintained throughout all the subsequent passages.
Figure 1 shows a comparison of the responses to
IGF1 and aldosterone in age-matched naive and OTA-
treated MDCK-C7 cells.
The MDCK-C7 cell line has a multiphasic response
to ADH (anti-diuretic hormone). Three temporally
separable transport events can be distinguished. In
chronological order over a 30-min time frame these are,
a transient anion secretion via CFTR (cystic fibrosis
transmembrane regulator), a verapamil- and Ba2+-sen-
sitive anion secretion or cation absorption and Na+
reabsorption via the epithelial Na+ channel (ENaC)
[13]. This response is depicted in Fig. 2, top panel. In
Fig. 2 (bottom panel) the responses of age-matched
MDCK-C7 cells which had been previously treated with
OTA are illustrated. The first two electrogenic responses
are very similar. Interestingly, however, the third ion
transport response, that of Na+ flux via ENaC, is
missing in the OTA-treated cells as evidenced by the lack
of amiloride-sensitive transport after 30 min. This lack
of amiloride-sensitive transport in the basal as well as
ADH-treated cells was also present if the amiloride was
added to OTA treated cells 15 min after hormone
addition (Fig. 3).
Previous studies suggested that the nature of the
initial transport peak is Cl and/or bicarbonate secre-
tion through the CFTR [13]. In contrast to Na+ trans-
port, the anion secretion is unchanged in magnitude or
nature of the ion transported in OTA-treated cells. In
accordance with previous studies, NPPB [5-nitro-2-(3-
phenylpropylamino)-benzoic acid], an inhibitor of
CFTR diminishes the first, transient peak in OTA
treated cells (Fig. 4, top panel). Pre-incubation in Cl-
free media (bilaterally) also diminishes the size of the
response (Fig. 4 , bottom panel).
The various components of the study shown in the
figures above were conducted using cells from 16–48
passages after treatment with OTA. A summary of
amiloride-sensitive transport is shown in Fig. 5.
A parsimonious explanation for the specific effect
on ENaC-mediated Na+ reabsorption would be that
the toxin inhibited the synthesis of one or more of the
three (a,b,c) subunits comprising the amiloride-sensi-
tive Na+ channel. Using subunit-specific antibodies
for each individual subunit [22], we demonstrate that
the synthesis and expression of these proteins is not
substantially altered in the OTA-treated cells (Fig. 6).
For the a and b subunits there was sufficient material
to detect both the core protein and the fully gly-
cosylated forms of the subunit while the c subunit was
detected predominately as the fully glycosylated pro-
tein. In all cases, the subunit proteins in the OTA-
treated cells were present in abundances that were
equal to or greater than identical proteins found in
the parental cell line.
The treatment with OTA had no adverse effect on
the high-resistance nature of the MDCK-C7 cell line.
In fact, the cells which were treated with the OTA
had a significantly higher transepithelial resistance
(Fig. 7).
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Discussion
Ingested OTA is concentrated in the kidney and has
been implicated as a nephrotoxin. Previous studies have
explored the effect of relatively high concentrations of
OTA in order to determine the nature of the toxic ac-
tions of this compound. However, low level exposures
are more applicable to what is normally found in the
majority of the population. Based on previous studies,
one of us (M.G.) has suggested that at physiologically
relevant concentrations, OTA does not act as a classic
toxin by altering cell viability but, rather, by modulating
renal cell function [1, 8].
We have modeled the low-dose, subtoxic cellular ef-
fects of the mycotoxin by studying functional conse-
quences in a principal cell line which responds to
hormonal stimuli by expressing polarized ion transport.
The dose chosen, 100 nM, was previously shown to be
devoid of effects on growth inhibition, protein content,
or transepithelial resistance in polarized, absorptive
intestinal cells [14]. In the MDCK-C7 cell line, 100 nM
OTA caused both phenotypic and genotypic changes as
previously reported [8]. After OTA treatment and sub-
sequent culture in OTA-free media, the cells demon-
strated numerical chromosomal aberrations, reduction
in electrolyte transport (K+ secretion), a loss of
Fig. 1 Comparison of Na+
transport responses to IGF1
and aldosterone in naı¨ve and
ochratoxin-A (OTA)-treated
MDCK-C7 cells. In these
representative experiments, ion
transport was measured as
short-circuit current (SCC) in
age-matched (9–10 days)
cultures grown on permeable
supports and mounted in
modified Ussing chambers. For
the electrophysiological studies,
the cells were bathed in serum-
free media. The top panel
illustrates the response to
100 nM IGF1 added to both
cultures at time t=0. Thirty
minutes later amiloride
(105 M) was added to both
cultures to determine the
proportion of the SCC due to
Na+ transport via epithelial
Na+ channels (ENaC). The
bottom panel illustrates the
response to 107 M aldosterone
added to both cultures at time
t=0. Five hours later amiloride
(105 M) was added to both
cultures as indicated by the
arrows
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responsiveness to aldosterone and an increase in trans-
cellular resistance [8].
In response to aldosterone or IGF1, confluent
MDCK-C7 cell monolayers exhibit an increase in
transepithelial Na+ transport in a reabsorptive direction
[2]. Here we have shown that the natriferic responses to
both the steroid or peptide hormones were completely
and irreversibly inhibited by the single OTA exposure.
Surprisingly, the hormonal responses did not return
when the cells were continued in culture for 48 passages.
These results are indicative of a genomic alteration in
the pathways controlling electrolyte transport in the cell
line. Next, we examined whether this change was global,
affecting multiple transporters, or whether it was more
specific. To discern between these possibilities, we
examined the acute response to ADH, a hormone that
stimulates the activity of three different transport phe-
nomena in a 30-min time frame in the MDCK-C7 cell
line [13].
Interestingly, two of the three transport systems
stimulated by ADH exhibited normal responses after
OTA treatment. The third, an increase in amiloride-
sensitive Na+ flux, was inhibited in the OTA-treated
cells. The initial transport phenomena, anion secretion
via CFTR, was present in the toxin-treated cells and had
the characteristics which we had previously demon-
strated in untreated cells. Therefore, the genomic effect
of low dose OTA seems to be a selective inhibition of
transport initiated via the apically situated ENaC.
Activation of ENaC secondarily stimulates K+ secre-
tion, thus accounting for the previous observations
regarding the K+ secretory response [4, 8].
Interestingly, the inhibition of transport is not due to
a decreased expression of the ENaC subunit proteins.
All subunits appear to be present in the OTA-MDCK-
C7 cells in amounts similar to, if not higher than, those
of the untreated line. Additional studies will be neces-
sary to elucidate the mechanism of action of the toxin
and such studies may also provide additional important
information regarding the regulation of ENaC, a chan-
nel which is clinically important because of its role in the
regulation of blood pressure.
Fig. 2 Comparison of ion transport responses to anti-diuretic
hormone (ADH) in naı¨ve and OTA-treated MDCK-C7 cells. Ion
transport was measured as SCC. For the electrophysiological
studies, the cells were bathed in serum-free media. ADH (10 mU/
ml) was added to the serosal bathing media as indicated at time
t=0. Amiloride (105 M) was added to the apical bathing media of
all cultures at time t=30 min. Symbols denote the mean±SEM.
The SEM bars are shown in the negative direction only. n=number
of experiments. The three distinct transport phenomena are
indicated by open arrows on the top panel. The third of these
transport events, an amiloride-sensitive component, is absent in the
experiments illustrated in the lower panel
Fig. 3 Short-term analysis of ion transport responses to ADH in
the MDCK-C7 cells which had been treated with OTA. Ion
transport was measured as SCC. For the electrophysiological
studies, the cells were bathed in serum-free media. ADH (10 mU/
ml) was added to the serosal bathing media as indicated at time
t=0. Amiloride (105 M) was added to the apical bathing media of
all cultures at time t=15 min. Symbols denote the mean±SEM.
The SEM bars are shown in the negative direction only. n=number
of experiments
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The functional effects which we have described in our
electrophysiological studies correlate with the observed
clinical effects of increased Na+ excretion and decreased
K+ excretion [4]. Furthermore, our results suggest that a
single exposure to OTA will have long-term effects on
Na+ transport in the principal cells since the mycotoxin
appears to exert an irreversible effect on function in the
exposed cells. This may have serious consequences for
salt and water balance since these are the hormone-
responsive cells in which transport is regulated in order
to maintain fluid and electrolyte homeostasis.
OTA has been shown to have additional effects on
other renal cell types. In an MDCK model of the
intercalated cells, the acute effect of OTA appeared to be
a blockage of anion conductance [5]. Moreover, in hu-
man immortalized kidney epithelial cells, nanomolar
OTA potentiated hormone-induced Ca2+ signaling and
proliferation [1].
OTA also selectively modulates transport in other
polarized epithelial cells. In cultured human intestinal
cell lines, HT-20–04 and Caco-2–14, micromolar con-
centrations of OTA inhibited Na+-dependent glucose
transport, stimulated the active transport of serine and
had no effect on cAMP-dependent Cl transport
through the CFTR [14]. The latter result agrees with our
own findings of selective inhibition of Na+ transport
with no effect on anion secretion via CFTR. Thus, OTA
may modulate various cellular transport systems and the
effects may be cell-type specific. Additional studies will
be required to determine whether the changes in other
cell types are also irreversible.
In contrast to studies employing higher toxin con-
centrations, the functional effects that we observed were
not accompanied by decreases in transepithelial resis-
tance. In fact, the toxin-treated cells exhibited a statis-
tically higher transepithelial resistance. This increased
resistance was maintained throughout the 48 passages
and is likely reflective of the reduced Na+ and K+
transport which are the major ion movements under
basal (non-hormone treated) conditions.
In primary cultures of proximal tubule cells, nanom-
olar concentrations of OTA had no effect on cell viability
or formation of transepithelial Na+ or K+ gradients.
Conversely, micromolar concentrations reduced cell
Fig. 4 Characterization of the initial transport response in
MDCK-C7 cells which had been treated with OTA. For the
electrophysiological experiments, cells were bathed in Kreb’s
Henseleit media. OTA-treated cells were preincubated with NPPB
(500 lM) for 30 min (top panel) or incubated in Cl–-free media
(bilaterally) for 1–2 h (bottom panel) before the addition of ADH
(10 mU/ml) to the serosal bathing media at time t=0. In the
experiment depicted in the top panel, amiloride (105 M) was added
to the apical bathing media of cultures at time t=15 min. In the
experimental set depicted in the bottom panel, amiloride was added
at time t=30 min. The amiloride-sensitive current was not shown
in the bottom panel but is negligible. Symbols denote the
mean±SEM. The SEM bars are shown in the negative direction
only. n=number of experiments
Fig. 5 Amiloride-sensitive SCC (ASCC) in MDCK-C7 cells as
compared with OTA-treated MDCK-C7 cells. Bars represent the
mean ASCC from a compilation of experiments using naı¨ve
MDCK-C7 cells or OTA-treated MDCK-C7 cells 16–48 passages
after treatment with the toxin. Bars are shown as mean±SEM
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viability, monolayer integrity and transepithelial ion
gradients [7]. These studies were substantiated in the
LLC-PK1 proximal tubule cell line, where micromolar
concentrations of OTA also caused a decrease in the
barrier function of the epithelial monolayer [10]. In
separate studies, micromolar concentrations also de-
creased the transcellular resistance of intestinal epithelial
cells [14]. Thus, there appears to be a biphasic effect on
resistance with nanomolar concentrations increasing,
and micromolar concentrations decreasing, the magni-
tude of the transepithelial resistance.
The biphasic changes in transepithelial resistances
may parallel the clinical changes that are noted after
OTA exposure. Low dose exposure has been shown to
have an effect on renal electrolyte transport and we have
modeled one aspect of that process here. This would
logically be expected to be paralleled by an increase in
resistance in tight epithelial monolayers. On the other
hand, decreases in transepithelial resistance indicate a
loss of junctional integrity and, thus, an increase in
junctional permeability. The loss of cellular resistance
has interesting clinical implications that may explain
some of the more toxic effects of high level exposure to
OTA. A loss of the barrier function of epithelial cells has
been postulated to contribute to the development of
malignancies [15]. Growth factors are small molecular
weight polypeptides which are easily filtered by the
glomeruli. Peptide hormones and growth factors in the
filtrate normally have no access to their cognate recep-
tors on the basolateral side of renal tubular epithelial
cells. However, as suggested by Mullin [15], when the
barrier function of the epithelial monolayer is breached,
the high concentration of growth factors which can
interact with the basolateral receptors may contribute to
the malignant transformation. This alteration of trans-
epithelial permeability may be one of the factors
responsible for the increased incidence of renal carci-
noma observed in instances of chronic, high exposures
to OTA.
In summary, our studies correlate with the clinical
observations of salt wasting after exposure to low doses
of OTA. Furthermore, these results indicate that the
effects of low dose toxin exposure appear to be irre-
versible and may, therefore, reflect genomic changes.
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